SynthesisFrontiers in immunology2026

Immunotherapy for TKI-resistant, EGFR L858R-mutated non-small cell lung cancer: a systematic review and meta-analysis of randomized and single-arm studies.

Peipei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.